Phenylephrine HCL (PF) 10% sterile ophthalmic solution is for topical ophthalmic use and used to dilate the eye before examination, surgery or to treat certain eye conditions.
- Volume: 4ml
- Concentration: 10%
- We exclusively compound Phenylephrine HCL (PF) ophthalmic solution for ophthalmic use only
- Compounded in a sterile compounding facility that is <795>, <797> and <800> chapter compliant
References:
- Fraunfelder FT, Scafidi AF. Possible adverse effects from topical ocular 10% phenylephrine. Am J Ophthalmol. 1978;85(4):447-453. PMID: 637240. https://pubmed.ncbi.nlm.nih.gov/637240/
- Loewenstein A, Zemel E, Lazar M, Perlman I. Cardiovascular effects of topical phenylephrine 10%. Arch Ophthalmol. 1994;112(5):656-660. PMID: 8185524. https://pubmed.ncbi.nlm.nih.gov/8185524/
- Bartlett JD, Jaanus SD. Clinical Ocular Pharmacology: Mydriatic and cycloplegic agents review. Surv Ophthalmol. 1988;33(6):453-465. PMID: 3057513. https://pubmed.ncbi.nlm.nih.gov/3057513/
Contact us to inquire about customizations and for detailed pricing information. Please note that all compounds require a valid, patient-specific prescription.